Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2021

View Archived Issues

CCR6 antagonist PF-07054894 for autoimmune disorders

International researchers discover first nonhormonal treatment target for endometriosis

Increased atrial proarrhythmic activity seen in murine model of OSA

Janssen Biotech divulges DHODH inhibitors

Mindset Pharma patents 5-HT2A receptor agonists

TroBio Therapeutics presents new compounds for cancer

U.K. researchers synthesize new antifungals

New benzimidazole derivative as a selective RORgamma inverse agonist for prostate cancer treatment

Scientists discover and characterize a selective hCYP11B2 PET tracer for primary hyperaldosteronism

New heart failure animal model also captures arrhythmia susceptibility

Low-dose targeted radionuclide therapy using [90Y]NM-600 promotes response to ICIs

New class of Mcl-1 inhibitors developed at Janssen for treating myeloma

Investigators identify new gene mutations behind hereditary optic neuropathy

Preclinical data highlight CAN-04 mode of action in potentiating efficacy of docetaxel

Genexine divulges new anti-PD-L1 fusion proteins

Satellos determines high-resolution crystal structure of target for Duchenne muscular dystrophy

Sonnet selects SON-1410 as development candidate for melanoma and renal cancers

Type of RPE65 variant is associated with age at onset of inherited retinal dystrophies

New genes identified to cause nonsyndromic cleft palate

Polymorphisms in the IRAK2 gene are associated with RA susceptibility

hsa-miR-34b-5p as novel diagnostic marker in male infertility

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...